Bexsero (GlaxoSmithKline Biologicals SA)


Welcome to the PulseAid listing for the Bexsero drug offered from GlaxoSmithKline Biologicals SA. This pharmaceutical is classified as a VACCINE. Below, you can view the details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same VACCINE drug type category.

LABELER NAME / MANUFACTURER: GlaxoSmithKline Biologicals SA
NON-PROPRIETARY NAME: NEISSERIA MENINGITIDIS SEROGROUP B NHBA FUSION PROTEIN ANTIGEN, NEISSERIA MENINGITIDIS SEROGROUP B FHBP FUSION PROTEIN ANTIGEN and NEISSERIA MENINGITIDIS SEROGROUP B NADA PROTEIN ANTIGEN
SUBSTANCE NAME: NEISSERIA MENINGITIDIS SEROGROUP B NHBA FUSION PROTEIN ANTIGEN; NEISSERIA MENINGITIDIS SEROGROUP B FHBP FUSION PROTEIN ANTIGEN; NEISSERIA MENINGITIDIS SEROGROUP B NADA PROTEIN ANTIGEN; NEISSERIA MENIN
TYPE: VACCINE
PHARMA CLASS:
ROUTE: INTRAMUSCULAR
DOSAGE FORM: INJECTION, SUSPENSION
MARKETING CATEGORY NAME: BLA
START MARKETING DATE: 2016-12-01
END MARKETING DATE: 0000-00-00


Bexsero VACCINE Details:

Item DescriptionBexsero from GlaxoSmithKline Biologicals SA
LABELER NAME: GlaxoSmithKline Biologicals SA
DEA SCHEDULE:
ACTIVE STRENGTH: 50; 50; 50; 25(ug/.5mL; ug/.5mL; ug/.5mL; ug/.5mL)
START MARKETING DATE: 2016-12-01
END MARKETING DATE: 0000-00-00
PRODUCT ID: 58160-976_a68650e0-73f3-406a-8d6f-563bebd0b8a1
PRODUCT NDC: 58160-976
APPLICATION NUMBER: BLA125546

Other NEISSERIA MENINGITIDIS SEROGROUP B NHBA FUSION PROTEIN ANTIGEN; NEISSERIA MENINGITIDIS SEROGROUP B FHBP FUSION PROTEIN ANTIGEN; NEISSERIA MENINGITIDIS SEROGROUP B NADA PROTEIN ANTIGEN; NEISSERIA MENIN Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
GlaxoSmithKline Biologicals SABexsero